Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

230
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
230

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CORR Insights®: What Proportion of Patients Treated With Calcium Phosphate and Calcium Sulfate Bone Substitutes for Benign Pediatric Bone Tumors Develop Recurrent Lesions?

Clinical orthopaedics and related research·2026
Same author

Prevalence of hyperprolific authors in sports medicine and musculoskeletal health and implications on research attention.

PloS one·2026
Same author

The Transformative Potential of Artificial Intelligence in Latin American Research.

The Journal of bone and joint surgery. American volume·2026
Same author

What's New in Machine Learning and Generative Artificial Intelligence in Orthopaedics.

The Journal of bone and joint surgery. American volume·2025
Same author

The Power of AI to Turn Words into Images.

The Journal of bone and joint surgery. American volume·2025
Same author

Changes in Clinical Practice After Publication of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Randomized Controlled Trial.

The Journal of the American Academy of Orthopaedic Surgeons·2025

Related Experiment Video

Updated: Aug 3, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.2K

Chondrosarcoma: A Clinical Review.

Aaron Gazendam1, Snezana Popovic2, Naveen Parasu3

  • 1Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON L8S 4L8, Canada.

Journal of Clinical Medicine
|April 13, 2023
PubMed
Summary
This summary is machine-generated.

Chondrosarcomas, diverse malignant tumors, vary in grade and behavior. Accurate diagnosis and grading are crucial for effective treatment and patient outcomes.

Keywords:
chondrosarcomareviewsarcoma

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

25.6K

Related Experiment Videos

Last Updated: Aug 3, 2025

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.2K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.3K
The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

25.6K

Area of Science:

  • Oncology
  • Pathology

Background:

  • Chondrosarcomas are malignant neoplasms producing cartilaginous matrix.
  • These tumors exhibit a spectrum of biologic activity, ranging from low-grade to high-grade malignancies.
  • Atypical cartilaginous tumors (ACTs) represent an intermediate category.

Purpose of the Study:

  • To highlight the diagnostic challenges in differentiating chondrosarcoma grades.
  • To emphasize the importance of histologic grade in clinical presentation, imaging, and pathology.
  • To underscore the variability in treatment and outcomes based on tumor grade.

Main Methods:

  • Review of chondrosarcoma classification and grading systems.
  • Analysis of clinical, radiographic, and pathologic features across different grades.
  • Discussion of diagnostic dilemmas, particularly distinguishing intermediate/high-grade tumors and low-grade tumors from benign enchondromas.

Main Results:

  • Histologic grade significantly influences chondrosarcoma presentation, imaging findings, and prognosis.
  • Accurate grading is essential for appropriate management strategies.
  • Distinguishing between low-grade chondrosarcomas, atypical cartilaginous tumors, and benign enchondromas poses a diagnostic challenge.

Conclusions:

  • Chondrosarcomas represent a heterogeneous group of tumors requiring precise grading.
  • Multidisciplinary team approach at specialized centers optimizes patient care.
  • Understanding the spectrum of chondrosarcoma biology is key to improving patient outcomes.